Rates of CPAP therapy termination in different obstructive sleep apnoea patient phenotypes: analysis of the French nationwide health claims database
J. Pepin (Grenoble, France), S. Bailly (Grenoble, France), P. Rinder (Paris, France), D. Adler (Geneva, Switzerland), D. Szeftel (Paris, France), A. Malhotra (San Diego, United States of America), P. Cistulli (Sydney, Australia), A. Benjafield (Sydney, Australia), F. Lavergne (Saint-Priest, France), A. Josseran (Saint-Priest, France), R. Tamisier (Grenoble, France), P. Hornus (Paris, France)
Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Pepin (Grenoble, France), S. Bailly (Grenoble, France), P. Rinder (Paris, France), D. Adler (Geneva, Switzerland), D. Szeftel (Paris, France), A. Malhotra (San Diego, United States of America), P. Cistulli (Sydney, Australia), A. Benjafield (Sydney, Australia), F. Lavergne (Saint-Priest, France), A. Josseran (Saint-Priest, France), R. Tamisier (Grenoble, France), P. Hornus (Paris, France). Rates of CPAP therapy termination in different obstructive sleep apnoea patient phenotypes: analysis of the French nationwide health claims database. 4387
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: